Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Boston Scientific Corporation

NYSE

Market Cap.

111.19B

Avg. Volume

6.26M

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Boston Scientific Corporation!

Still processing it, give me a bit more time...

Boston Scientific Corporation News

Boston Scientific Corporation Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Devices
bostonscientific.com

About Boston Scientific Corporation

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Boston Scientific Corporation Earnings & Revenue

Boston Scientific Corporation Financials

Table Compare

Compare BSX metrics with:

   

Earnings & Growth

BSX

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

BSX

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

BSX

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

BSX

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Boston Scientific Corporation Income

Boston Scientific Corporation Balance Sheet

Boston Scientific Corporation Cash Flow

Boston Scientific Corporation Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsNeutral
Return on EquityBuy
Return on AssetsBuy
Debt/Equity RatioBuy
Price/Earnings RatioStrong Buy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Boston Scientific Corporation Executives

NameRole
Mr. Michael F. MahoneyChairman, President & Chief Executive Officer
Mr. Daniel J. BrennanExecutive Vice President & Chief Financial Officer
Mr. Joseph M. FitzgeraldExecutive Vice President & Group President of Cardiology
Mr. Arthur Crosswell ButcherExecutive Vice President and Group President of MedSurg & Asia Pacific
Mr. Jeffrey B. MirvissExecutive Vice President & President of Peripheral Interventions
NameRoleGenderDate of BirthPay
Mr. Michael F. MahoneyChairman, President & Chief Executive OfficerMale19654.83M
Mr. Daniel J. BrennanExecutive Vice President & Chief Financial OfficerMale19662.15M
Mr. Joseph M. FitzgeraldExecutive Vice President & Group President of CardiologyMale19641.84M
Mr. Arthur Crosswell ButcherExecutive Vice President and Group President of MedSurg & Asia PacificMale19711.49M
Mr. Jeffrey B. MirvissExecutive Vice President & President of Peripheral InterventionsMale19661.44M

Boston Scientific Corporation Insider Trades

Date22 May
NameBrennan Daniel J.
RoleEVP and CFO
TransactionAcquired
TypeM-Exempt
Shares16863
Date22 May
NameBrennan Daniel J.
RoleEVP and CFO
TransactionAcquired
TypeM-Exempt
Shares16863
Date22 May
NameBrennan Daniel J.
RoleEVP and CFO
TransactionAcquired
TypeM-Exempt
Shares15642
Date22 May
NameBrennan Daniel J.
RoleEVP and CFO
TransactionAcquired
TypeM-Exempt
Shares15086
Date22 May
NameBrennan Daniel J.
RoleEVP and CFO
TransactionDisposed
TypeS-Sale
Shares64454
DateNameRoleTransactionTypeShares
22 MayBrennan Daniel J.EVP and CFOAcquiredM-Exempt16863
22 MayBrennan Daniel J.EVP and CFOAcquiredM-Exempt16863
22 MayBrennan Daniel J.EVP and CFOAcquiredM-Exempt15642
22 MayBrennan Daniel J.EVP and CFOAcquiredM-Exempt15086
22 MayBrennan Daniel J.EVP and CFODisposedS-Sale64454

Discover More

Streamlined Academy

Boston Scientific Corporation

NYSE

Market Cap.

111.19B

Avg. Volume

6.26M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Boston Scientific Corporation News

Boston Scientific Corporation Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Boston Scientific Corporation Earnings & Revenue

Boston Scientific Corporation Income

Boston Scientific Corporation Balance Sheet

Boston Scientific Corporation Cash Flow

Boston Scientific Corporation Financials Over Time

Boston Scientific Corporation Executives

NameRole
Mr. Michael F. MahoneyChairman, President & Chief Executive Officer
Mr. Daniel J. BrennanExecutive Vice President & Chief Financial Officer
Mr. Joseph M. FitzgeraldExecutive Vice President & Group President of Cardiology
Mr. Arthur Crosswell ButcherExecutive Vice President and Group President of MedSurg & Asia Pacific
Mr. Jeffrey B. MirvissExecutive Vice President & President of Peripheral Interventions
NameRoleGenderDate of BirthPay
Mr. Michael F. MahoneyChairman, President & Chief Executive OfficerMale19654.83M
Mr. Daniel J. BrennanExecutive Vice President & Chief Financial OfficerMale19662.15M
Mr. Joseph M. FitzgeraldExecutive Vice President & Group President of CardiologyMale19641.84M
Mr. Arthur Crosswell ButcherExecutive Vice President and Group President of MedSurg & Asia PacificMale19711.49M
Mr. Jeffrey B. MirvissExecutive Vice President & President of Peripheral InterventionsMale19661.44M

Boston Scientific Corporation Insider Trades

Date22 May
NameBrennan Daniel J.
RoleEVP and CFO
TransactionAcquired
TypeM-Exempt
Shares16863
Date22 May
NameBrennan Daniel J.
RoleEVP and CFO
TransactionAcquired
TypeM-Exempt
Shares16863
Date22 May
NameBrennan Daniel J.
RoleEVP and CFO
TransactionAcquired
TypeM-Exempt
Shares15642
Date22 May
NameBrennan Daniel J.
RoleEVP and CFO
TransactionAcquired
TypeM-Exempt
Shares15086
Date22 May
NameBrennan Daniel J.
RoleEVP and CFO
TransactionDisposed
TypeS-Sale
Shares64454
DateNameRoleTransactionTypeShares
22 MayBrennan Daniel J.EVP and CFOAcquiredM-Exempt16863
22 MayBrennan Daniel J.EVP and CFOAcquiredM-Exempt16863
22 MayBrennan Daniel J.EVP and CFOAcquiredM-Exempt15642
22 MayBrennan Daniel J.EVP and CFOAcquiredM-Exempt15086
22 MayBrennan Daniel J.EVP and CFODisposedS-Sale64454

Streamlined Academy

Website screenshot
HealthcareMedical - Devices
bostonscientific.com

About Boston Scientific Corporation

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Boston Scientific Corporation!

Still processing it, give me a bit more time...

Boston Scientific Corporation Financials

Table Compare

Compare BSX metrics with:

   

Earnings & Growth

BSX

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

BSX

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

BSX

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

BSX

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Boston Scientific Corporation Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsNeutral
Return on EquityBuy
Return on AssetsBuy
Debt/Equity RatioBuy
Price/Earnings RatioStrong Buy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More